A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease.
about
A functional role for CCR6 on proallergic T cells in the gastrointestinal tractShining a light on intestinal trafficAdhesion Molecules Associated with Female Genital Tract InfectionCCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cellsNovel genetic markers in inflammatory bowel disease.High fat diet accelerates pathogenesis of murine Crohn's disease-like ileitis independently of obesityTargeted intestinal epithelial deletion of the chemokine receptor CXCR4 reveals important roles for extracellular-regulated kinase-1/2 in restitution.A Novel Peroxisome Proliferator-activated Receptor (PPAR)γ Agonist 2-Hydroxyethyl 5-chloro-4,5-didehydrojasmonate Exerts Anti-Inflammatory Effects in ColitisRapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration.Novel susceptibility genes in inflammatory bowel disease.CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis.Lymphocyte homing and its role in the pathogenesis of IBD.New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools.Gene expression patterns in experimental colitis in IL-10-deficient miceThe functional significance behind expressing two IL-8 receptor types on PMN.CCR6 marks regulatory T cells as a colon-tropic, IL-10-producing phenotypeTargeting T-cell migration in inflammatory bowel disease.Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives.Oral administration of docosahexaenoic acid attenuates colitis induced by dextran sulfate sodium in mice.Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection.Enterotoxin-producing staphylococci cause intestinal inflammation by a combination of direct epithelial cytopathy and superantigen-mediated T-cell activation.Giardia lamblia-induced changes in gene expression in differentiated Caco-2 human intestinal epithelial cells.Characterization of intestinal inflammation and identification of related gene expression changes in mdr1a(-/-) mice.High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.Forced treadmill exercise training exacerbates inflammation and causes mortality while voluntary wheel training is protective in a mouse model of colitisCCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.Higher levels of CCL20 expression on peripheral blood mononuclear cells of chinese patients with inflammatory bowel disease.Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis.In vitro enteroid-derived three-dimensional tissue model of human small intestinal epithelium with innate immune responses.Targeting tumour necrosis factor receptor 1 assembly reverses Th17-mediated colitis through boosting a Th2 response.Molecular profiling of a rat model of colitis: validation of known inflammatory genes and identification of novel disease-associated targets.Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment.Adiponectin and adiponectin receptor 1 overexpression enhance inflammatory bowel disease.Anti-inflammatory effects of epidermal growth factor on the immature human intestine
P2860
Q24655787-D863CA6A-F41B-40AB-9601-BE68FF2DDB67Q26863227-6AE57F1C-B7C5-45EC-A29B-D5BFA861FAFAQ27342392-D06D79BA-663A-4073-9852-E2751C8860D7Q28583123-6ED5463B-BF41-403F-A7EF-F166FD01A69FQ34233119-87870953-3E6D-4175-A7E2-7AD273563A44Q34971829-4FC3390E-B961-498D-89D9-81C79D2198FDQ35197000-FE5A47BA-20F1-48EA-972C-63ADB0C10E7AQ36283368-4C14700B-97E4-459C-8CF9-3C4C4959210AQ36423910-F832D05B-EAAA-4FDC-A620-FC8BD663A7D3Q36446297-BAE6B26C-1704-462E-AA45-5E01048D4A77Q36631416-0E9508E4-D11F-48F2-BA26-B271A297D8ABQ37130397-F245597E-AF1D-4277-83BA-DE3835AC2E5FQ37206175-95A6246E-0328-45F6-874C-743367C3B2F5Q37391156-F485A5A0-AE11-44CA-9046-25C81A891841Q37535397-74E80808-D912-4A8A-A9B5-CE91C73F7733Q37599020-EC379B3C-0756-4F80-A9C2-52FF17431D41Q38040430-D7B93543-2D22-4255-B98E-CD98AF5F18F6Q38112106-188C6BF7-EFB4-48CB-BB8F-4C0E25E024F8Q38341042-3C4BDDFE-2BE7-4B38-9A11-9025F7313DC1Q38764707-C57BFBC7-2FEC-4ED4-AD4E-A58E592A157EQ39480384-4D3E1999-6C4C-4CDE-B04A-CD40328DC8A8Q40380834-DC065671-3020-46FB-87FD-1A03BE84BD5AQ40622345-B35F975D-BFAF-482B-8347-5CF71F928BBFQ41185159-94620054-468D-4339-8458-3BDB6027C7D2Q42630337-C950D3C1-44A5-483A-811E-9774E20E506EQ43133908-CD4738EF-316A-4BBC-A55B-C1E6F33A69CEQ43197765-FE3E4D63-AE9D-4061-9DB8-72AA87DD8AB6Q43849278-700DEF89-A56E-4857-BF1D-A00E4703800EQ47109988-6E9E024B-6DA8-4EB3-96D9-BA31E88C6539Q50793590-95410EA8-BE43-426E-A40E-24C08B8B3570Q51783011-78975EA3-2FA4-465E-83CD-F1575722103AQ54387452-06C74A6A-8790-42D8-995B-5CA6D78846FEQ55001202-A5A1A4C3-F52B-4E49-B955-26C58DB36C23Q57118129-3F297013-CE5F-4E28-85AC-DD1702B781EC
P2860
A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A distinct subset of chemokine ...... in inflammatory bowel disease.
@en
type
label
A distinct subset of chemokine ...... in inflammatory bowel disease.
@en
prefLabel
A distinct subset of chemokine ...... in inflammatory bowel disease.
@en
P2093
P2860
P1476
A distinct subset of chemokine ...... in inflammatory bowel disease.
@en
P2093
Bingham AH
P2860
P304
P356
10.1111/J.1365-2036.2004.02262.X
P407
P577
2005-01-01T00:00:00Z